In this regard, they showed no reaction of the responder T-cells to unmodified melanoma cells and did not study how these responder cells would specifically respond to modified or unmodified melanoma antigens (i.e., gp100 or HMW-MAA) that are known to elicit a T-cell response [29, 136]. The gene discussed is PMEL; the disease is melanoma.